539 news items
Page 7 of 27
v15yslatcu4yccqwbq3oy1s1azv7h4xg2nzbsv08ogz4xm4o0
PHIO
11 Apr 24
: Cancer-Immunotherapy and Cancer VaccinesAuthors: Melissa Maxwell, Linda Mahoney, Mary Spellman
syaz1m37y9avitd8k9b7dr 7553079
SNGX
11 Apr 24
™ Heat Stable Vaccine Seven Years of U.S. Market
y9ijko6wogjik76c de8q4g5xqrz7vz
ADMA
ANIP
MRK
11 Apr 24
, in certain patients with head and neck cancer. The INT is being developed in collaboration with Merck
nxbztiiznxbv3qgkv88ugvuw94saek53noqufi3l8q8ui79g1
11 Apr 24
, Stephen and Barbara Friedman Chair, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA
rntut7f9iuqvi9z208uu27cb9k nft6gb56h65y1qer6coxs
10 Apr 24
-- TAC-001, Tallac's lead immunostimulatory ADC program, potentiates cancer vaccine
uefik73lkfiximd7u3f2wqdcivsf9deyoh0a303t028jvoqd95593pf0m
BMY
JNJ
MRK
10 Apr 24
) ended 2023 with good news regarding their joint cancer vaccine and combined treatment that prevents recurrence and lowers the risk of the worst-case
s1mn12si5s6gymrba9x4dzg7p60i06tbep4240lozv7le2hcy3
10 Apr 24
Skin CancerOther Indications By Route of Administration
tngbdgud8f7y4 zlf75
10 Apr 24
personalized cancer vaccines and targeted treatments for various ailments, capitalizing on the platform's versatility and efficacy
dzmvrjcjwbkmo3t9b47vrrapzu0x2ryxb0f8r4534p32a 4fj3v9vt751
10 Apr 24
to ease human suffering from infectious diseases, cancer, and rare diseases by leveraging our innovative technologies and in-depth know-how. Batavia
4w7kr8qhs8d36x302u190er3ng0nag3gp0b7c29hewvyz
10 Apr 24
Raised more than $1.8M through the Annual Pediatric Cancer
dvil482hokla1jg94hynolnpt7ohee1v2c18
10 Apr 24
cancer, DPX™-RSV for Respiratory Syncytial Virus, and BVX-0918, a personalized immunotherapeutic vaccine using its proprietary HapTenix©
ims5psd80f7eaz08v8mx8vxpsc
10 Apr 24
is positioned for robust growth driven by the rising burden of chronic diseases like cancer and autoimmune disorders. These conditions fuel the need
yn0qfb b6uxsu3bbk441hvk9rms59yaox0cu1
9 Apr 24
and enhancing the lives of individuals battling cancer worldwide. Currently serving as the Vice President of Global Vaccines Strategy & New Products
j9okr2lr
VBIV
9 Apr 24
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI
uii4qj0o80koajzfig8 mf0y3mlhqvt6mn9l6pho0es4ipzay9
MRK
MRNA
9 Apr 24
patients in patients with a type of head and neck cancer, the vaccine showed a positive response.
mRNA-4157 + pembrolizumab was associated
1sgbg4g5q7cile89ga52ll14m0fabsrwxabbbcsdwu4dlm5kkajg5
CSCO
DIA
FCX
9 Apr 24
. (NASDAQ:MRNA) surged over 5% following promising results from an early study of the company’s cancer
g53r3tcv8k70cj53x890 aok8fc0fhvn9rjfwevqb8ja2vkn52vc7
9 Apr 24
azer-cel (azercabtagene zapreleucel) which targets CD19 to treat blood cancers. Our pipeline also includes multiple immunotherapy B-cell vaccine
twp42560v2
RAPT
9 Apr 24
inhibitors, immune stimulators, cancer vaccines and adoptive T cell therapy. About RAPT Therapeutics, Inc. RAPT
rg0fzgdhx99ta10x1nt ygk7fp8p
IOBT
9 Apr 24
biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today shared new data related
qi6so3tmvmc1rdymqqhg3d4o1gdv5v69ndjkpb8
9 Apr 24
neoantigen cancer vaccine, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA. These data